Ranbaxy Board Approves Separate Research Unit, Plans Share Listing This Year

NEW DELHI - Ranbaxy Laboratories' board Feb. 19 approved setting up a research unit called Ranbaxy Life Science Research Ltd., the latest foray by Indian generic pharma firms to create dedicated research and development arms to cut expenses on the parent balance sheet and attract new contract business

More from Archive

More from Scrip